Skip to main content

Roche’s virtual EHA 2023 event: Crovalimab in Hematology and Nephrology

Roche has hosted a virtual event on Monday, 12 June

Agenda
WelcomeBruno Eschli, Head of Investor Relations
Roche hematology franchise and crovalimab deep-divePeter Ahnesorg, Franchise Head Hematology, Global Product Strategy
Key crovalimab data presented at EHA 2023Prof. Alexander Röth, MD, West German Cancer Center, University Hospital Essen
Roche nephrology franchise strategy and pipelineJay Garg, MD, Global Development Head of Nephrology and Rheumatology
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events, Past IR Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments.

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.